Class Action

Advil, Tylenol, DayQuil, NyQuil, TheraFlu, Sudafed, and Other Cold and Flu Medicines

Class Action

Advil, Tylenol, DayQuil, NyQuil, TheraFlu, Sudafed, and Other Cold and Flu Medicines


Case Name (Date)

Chamberlain et al. v. Johnson & Johnson Consumer Inc., RB Health LLC, GlaxoSmithKline Consumer Healthcare Holdings (US), LLC
23-cv-4435, E.D. Penn.
(Nov. 2023)

Travis et al. v. Procter & Gamble Co., Kenvue, Inc., McNeil Consumer Healthcare, Reckitt & Benckiser LLC and GlaxoSmithKline, LLC
23-cv-607, S.D. Ohio
(Sept. 2023)


Product/Service

Advil, Tylenol, DayQuil, NyQuil, TheraFlu, Sudafed, and other cold and flu medicines


Allegations

Falsely marketing that medicines are decongestants when the active ingredient (phenylephrine) is not an effective decongestant


Status

Pending



Class-Action Tracker

Benefiber Prebiotic Powder

Class Action

Benefiber Prebiotic Powder

In November 2020, a class-action lawsuit was filed against GSK Consumer Health for allegedly falsely advertising Benefiber prebiotic powders as “100% Natural” when, according to plaintiffs, the powders contain wheat…

Benefiber Prebiotic Supplement

Class Action

Benefiber Prebiotic Supplement

In August 2020, a class-action lawsuit was filed against GlaxoSmithKline Consumer Healthcare for allegedly misleadingly advertising Benefiber Prebiotic Supplement as “100% Natural” when, according to plaintiffs, the company uses a…


The Latest

Filters


Show More